Robert Breedon > Gowling WLG > Birmingham, England > Lawyer Profile

Gowling WLG’s ‘commercially savvy’ and ‘modern, forward-looking practice’ is ‘continually thinking about how best to meet the client’s requirements’ on large-scale and business-critical commercial agreements. The team has experience in route-to-market issues, supply chain contracts, strategic alliances, outsourcings and procurement arrangements and in handling large national and international projects; in a recent highlight, the team acted for the Birmingham 2022 Commonwealth Games on all commercial issues relating to the delivery of the games. David Lowe heads up the group, which also fields the ‘pragmatic and commercial’ Sarah Riding and Robert Breedon, who advises public sector and healthcare clients.

Gowling WLG’s cross-departmental life sciences sector group handles the full spectrum of life sciences work encompassing transactions, patent disputes, regulatory issues and commercial work. The team counts several high-profile pharmaceutical companies on its client roster, including AstraZeneca and BioNTech. The firm also fields a distinct health and care team, which acts for a range of health and care service providers and investors, and is highly regarded for its real estate work relating to care homes and senior living facilities. Patrick Duxbury and Robert Breedon lead the group; Duxbury focuses on life sciences transactions and Breedon handles corporate work in the health and care sectors.

Gowling WLG is especially capable at handling large scale health and social care transactions. The firm has aided clients that have been critical to the COVID-19 response including AstraZeneca, the Office for National Statistics and the Department of Health and Social Care. Robert Breedon  advises the DHSC’s Test and Trace Team. Hugh Maule specialises in corporate transactions, private equity and venture capital matters.